ArticlePDF Available

The prevalence of transient and permanent congenital hypothyroidism in infants of Kurdistan Province, Iran (2006-2014)

Authors:

Abstract

Background: Congenital hypothyroidism (CH) is the most common endocrine diseases and one of the major causes of preventable mental retardation. This study was conducted to investigate the prevalence of transient and permanent congenital hypothyroidism in Kurdistan province, Iran. Materials and Methods: In this cross-sectional study, all registered congenital hypothyroidism neonate of health centers of cities covered by Kurdistan University of Medical Sciences during 2006 to 2014 entered to study. Demographic and laboratory information of CH neonates was collected and entered into the Stata-12 and was analyzed using student t-test and Chi-square statistic and P- value less than 0.05 was considered. Results: Overall incidence rate during 2006 to 2014 for province was 1.8, 2.3, 3.2, 4.3, 3.3, 4.0, 3.6, 4.6 and 2.7, respectively per 1000 neonates in this period. The number of diagnosed patients was 855 cases including 519 (60.7%) boys and 336 (39.3%) girls who 516 (60.4%) cases were from urban areas. Of the total patients, 202 (22.6%) were permanent. There was no significant difference between gender, location, type of childbirth, and season of birth with transient and permanent types of disease (P > 0.05); while, there was a significant statistical relationship between consanguineous marriages and congenital hypothyroidism (P < 0.05). Conclusion: The prevalence of congenital hypothyroidism in Kurdistan province is significantly higher than the global and country levels that emphasize the continuation and reinforcement of screening program of infants. Therefore, complementary studies are research priorities of the health system in Kurdistan province in order to clarify the environmental and genetic factors related.
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb.2017 4309
Original Article (Pages: 4309-4318)
http:// ijp.mums.ac.ir
The Prevalence of Transient and Permanent Congenital
Hypothyroidism in Infants of Kurdistan Province, Iran (2006-2014)
Zaher Khazaei1, Elham Goodarzi2, Ebrahim Ghaderi1, Salman Khazaei3, Alireza Alikhani4,
Saeeid Ghavi5, Kamyar Mansori6, Erfan Ayubi7, Behzad Gholamaliee8, Reza Beiranvand9,
Seyedeh Leila Dehghani10, Nahid Ghotbi11, Sairan Nili12
1
1Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran. 2Social
Determinants of Health Research Centre, Medical School, Rafsanjan University of Medical Science, Rafsanjan,
Iran. 3Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical
Sciences, Tehran, Iran. 4Deputy of Medical Education Development Center, Kermanshah University of Medical
Sciences, Kermanshah, Iran. 5Social Determinants of Health Research Center, Department of Public Health,
Birjand University of Medical Sciences, Birjand, Iran. 6Social Development and Health Promotion Research
Center, Gonabad University of Medical Sciences, Gonabad, Iran. 7PhD Candidate of Epidemiology, Department of
Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 8Msc in
Health Education, Hamadan University of Medical Sciences, Hamadan, Iran. 9MSc Department of Health and
Community Medicine, Faculty of Medicine, Dezful University of Medical Sciences, Dezful, Iran. 10Department of
Public Health, Behbahan Faculty of Medical sciences, Behbahan, Iran. 11Associate Professor, Cellular & Molecular
Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran. 12PhD Student of Epidemiology,
Kerman University of Medical Sciences, Kerman, Iran.
Abstract
Background: Congenital hypothyroidism (CH) is the most common endocrine diseases and one of the
major causes of preventable mental retardation. This study was conducted to investigate the
prevalence of transient and permanent congenital hypothyroidism in Kurdistan province, Iran.
Materials and Methods: In this cross-sectional study, all registered congenital hypothyroidism
neonate of health centers of cities covered by Kurdistan University of Medical Sciences during 2006
to 2014 entered to study. Demographic and laboratory information of CH neonates was collected and
entered into the Stata-12 and was analyzed using student t-test and Chi-square statistic and P- value
less than 0.05 was considered.
Results: Overall incidence rate during 2006 to 2014 for province was 1.8, 2.3, 3.2, 4.3, 3.3, 4.0, 3.6,
4.6 and 2.7, respectively per 1000 neonates in this period. The number of diagnosed patients was 855
cases including 519 (60.7%) boys and 336 (39.3%) girls who 516 (60.4%) cases were from urban
areas. Of the total patients, 202 (22.6%) were permanent. There was no significant difference between
gender, location, type of childbirth, and season of birth with transient and permanent types of disease
(P˃0.05); while, there was a significant statistical relationship between consanguineous marriages and
congenital hypothyroidism (P<0.05).
Conclusion: The prevalence of congenital hypothyroidism in Kurdistan province is significantly
higher than the global and country levels that emphasize the continuation and reinforcement of
screening program of infants. Therefore, complementary studies are research priorities of the health
system in Kurdistan province in order to clarify the environmental and genetic factors related.
Key Words: Congenital hypothyroidism, Hypothyroidism, Neonate, Iran.
*Please cite this article as: Khazaei Z, Goodarzi E, Ghaderi E, Khazaei S, Alikhani A, Ghavi S, Mansori K, et
al. The prevalence of Transient and Permanent Congenital Hypothyroidism in Infants of Kurdistan Province
(2006-2014). Int J Pediatr 2017; 5(2): 4309-18. DOI: 10.22038/ijp.2016.7902
*
Corresponding Author:
Sairan Nili. Dept of Epidemiology, Kerman University of Medical Sciences, Kerman, Iran.
Email: nele_sayran@yahoo.com
Received date Nov.03, 2016; Accepted date: Dec 12, 2016
Effect of Video Game Play on Pain
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4310
1- INTRODUCTION
Hypothyroidism is the result of decrease
in thyroid hormone synthesis or deficiency
in activity of thyroid hormone receptors.
The most common cause of congenital
hypothyroidism is disorder of complete or
partial development of the thyroid gland or
disorder of inappropriate replacement of
thyroid during the fetal period (Entopic
Gland) (1). CH is one of the major causes
of preventable mental retardation in
infants. Hypothalamic-pituitary-thyroid
axis starts its activity in the middle of fetal
life and evolves until birth of term infant.
Existence of hypothyroidism in the fetus
leads to some disorders in major organs
including the central nervous system and
the skeleton (2). Most infants seem quite
normal at birth, but children with signs of
precocious puberty and short stature and
delayed bone age should be sought for
hypothyroidism (3). Currently, almost all
the industrialized countries of the world
carry out the screening program for
neonatal hypothyroidism systemically (4).
Developing countries also gradually carry
out the screening program for neonatal
hypothyroidism at different scales. Its
implementation has also started in Iran
since 1997 (5). Before beginning screening
programs, early diagnosis of the disease is
usually conducted with delay due to the
low and non-specificity of signs and
symptoms in the first days of life, and this
issue is associated with the loss of
Intelligence Quotient (IQ) to various
degrees in patients (6). Congenital
hypothyroidism disease can lead to the
most important and major problems in
patients including failure to weight gain,
physical growth slowdown, delay in the
overall growth of the body and growth
failure of these children that is often
remained unknown (7). Congenital
hypothyroidism can be referred when
Thyroid-Stimulating Hormone (TSH) is
greater than 5mu/l of heel sample in
infants 3-5 days on filter paper (S&S 903
paper) and confirmation with venous blood
samples TSH is greater than 10mu/l and
thyroxine (T4) less than 6.5gr/dl (8).
Congenital hypothyroidism is divided into
two groups as permanent and transient.
The transient type is automatically
improving, while; the person has to take
medicine for the rest of his life in the
permanent type (9). Transient
hypothyroidism is thyroid symptoms at the
time of birth which are disappeared
spontaneously and thoroughly within a few
weeks or months (9). The most common
cause of transient hypothyroidism has been
reported iodine deficiency in the world.
Other causes of excessive consumption of
iodine are consumption of anti-thyroid
medications or presence of antibodies
against the thyroid during pregnancy (10).
In general, the incidence rate of disease in
the world has been estimated 1 in every
3,000-4,000 live births. According to
research conducted, prevalence spectrum
of CH in the world varies from 7.14 per
1000 births in Nigeria (2) to 14 per 1000
births in Japan (9). Based on studies
conducted in Iran, the incidence of this
disorder has been reported about 1 in 400
to 1 in 900 live births which is much
higher than the global average (10).
Results of studies from other countries
have shown that the prevalence of this
disease is 1 in 650 in Turkey (12), 1 in
1000 in France (13), 1 in 800 in Greece
(14), 1 in 2,372 in America (15), 1 in
2,640 in India (16), and in several studies
this amount is about 1 in 400 to 1 in 900
live births (17). National studies had
different results in this regard, so that
prevalence of this disease was ranged from
1 in 1000 in Tehran, 1 in 370 in Isfahan
(18), and 1 in 303 in Kashan (19), to 1 in
1433 live births in Shiraz (20). The
incidence of this disease in Kurdistan
province which is one of the western
provinces of Iran and a mountainous area
is higher and about 1 in 400 live births
(10).
Kaheni et al.
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4311
Given the relatively high prevalence of this
disease in Kurdistan province and its
importance in the creation of mental
retardation in children, we decided to
investigate the prevalence of congenital
hypothyroidism in Kurdistan province
during 2006 to 2014.
2- MATERIALS AND METHODS
2-1. Study Design and Population
This cross-sectional study was
conducted on children with neonatal
hypothyroidism. In this we used the data
collected from the CH screening in
Kurdistan Province, Iran, from August
2006 to August 2014. National screening
program for early detection of CH was
conducted by Iranian Ministry of Health
and Medical Education (MOHME) in all
provinces in 2005 and has been in progress
up to now. Kurdistan is located in west of
Iran, and according to National Census, in
2011 population of Kurdistan province
was 1,493,645 out of which 66% lived in
urban area. The capital of Kurdistan
province is the city of Sanandaj and other
counties are Marivan, Baneh, Saqqez,
Qorveh, Bijar, Kamyaran, Dehgolan,
Diwandarreh and Sarvabad.
2-2. Methods
According to the neonatal hypothyroidism
screening program, a few drops of blood
from the baby's heel is poured onto the
filter paper by the Lancet on the third to
fifth day of birth, and will be sent to the
newborn screening laboratories in the
provincial capitals by express post after
being dried which usually takes 3 hours.
After testing and determining the amount
of TSH, if it is less than 5 mu/L, it will be
known as a healthy infant otherwise as
suspected cases. And if amount of TSH is
5-9.9, the second filter paper is taken and
if it is more than 10, it will be referred to
the focal point in order to conduct serum
tests and approve or reject the disease.
Start treatment is ideal about 2 weeks to 3
weeks after birth (21). Treatment of
infected infants starts with a dose of 10 to
15 μg / mg levothyroxine medication.
After 3 years of treatment, in order to
determine whether permanent or transient
disease, treatment is discontinued for 2-4
weeks and tests are repeated. If the
transient disease is normal, treatment will
be discontinued otherwise it is permanent
and medication must be consumed until
the end of life (22).
In this program, heel prick blood samples
have been taken on Whatman filter papers
for infants by trained staff, mostly within
3-5 days of birth. They dry and
immediately transfer to the reference
screening laboratory of the province by
express mail service. Thyroid stimulating
hormone (TSH) test using the enzyme
linked immunosorbent assay (ELISA)
method. In this study according National
screening program TSH less than 4mu/l
and 5mu/l were considered normal for 3-7
day-old and 8 day- old neonates,
respectively. Then, the neonates with TSH
more than normal were selected. In order
to distinguish between permanent and
transient cases of CH, levothyroxine (LT4)
therapy was discontinued for 4 weeks in
children who were 3 years old, after
which time thyroid function tests (T4 and
TSH) were evaluated by the same
laboratory methods and the same
enzymatic kits. If the thyroid function tests
showed a high TSH with low T4, the
patient was diagnosed to have permanent
CH.
2-3. Measuring tools
We used registered data for each patient
which exists in Kurdistan deputy of health.
Information including gender (boy/girl),
location (rural/urban), county, date of
birth, parental consanguinity
(present/absent), delivery type
(Natural/cesarean section), birth weight,
length of infant and TSH and T4 level at
first measurement (mIU/L) were extracted
from this checklist.
Effect of Video Game Play on Pain
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4312
2-4. Eligibility criteria
Eligibility for including in this study were
cases had CH diagnosed by a newborn
screening program and confirmed by
venous blood samples, and also if they had
been treated with levothyroxine, and were
followed up closely in the first three years
of life.
2-5. Ethical considerations
Data were obtained with the consent of the
Kurdistan Deputy Health. And data were
in possession of researchers without a
patient's name.
2-6. Data analyses
Incidence rates were calculated per 1,000
live births by county for each year from
2006 to 2014. The average annual rate of
reduction (increase) (AARR [I]) was
calculated using a regression analysis to
quantify the rate of change of the
incidence from 2006 to 2014. In this
regression model, the incidence rate for
each county was considered as dependent
and the year as independent variable.
Then, using the coefficient (B) obtained
the AARR/I was calculated by the
following formula: AARR= 1-exp (B).
By using GIS software, map location of
CH cases in the province was drowning.
Frequency, mean and standard deviation
(SD) for demographic data according CH
type (permanent/transient) in neonates
were estimated. Qualitative variables were
compared using the Chi-square test and
quantitative variables were compared by t-
test. In this study, P-values less than 0.05
were considered significant. Statistical
analyses were performed using the Stata
software, version 12.0 (Stata Corp, College
Station, TX, USA).
3- RESULTS
According CH register data available in
Kurdistan deputy of health, 855 CH
patients were registered during 9 years
period (March 2006 to March 2014).
Among 855 neonates with CH, 202
(22.6%) of them were permanent CH and
544 (63.6%) were transient CH, 519
(60.7%) were boy and 336 (39.3%) were
girls (boy: girl ratio 1.54:1). 516 (60.4%)
of them were lived in urban areas. Chi-
square test showed no statistically
significant relation between gender
(P=0.1) and location (P=0.67) with CH
type. Neonates with the consanguine
parents had the significantly higher
proportion of permanent CH (29.7%)
compared parents without consanguinity
(20.8%) (P=0.03).
608 (71.1%) of neonates were born natural
and 247 (28.9%) were born with cesarean
section; there was no significance relation
between delivery type and CH type
(P=0.3). 239 (28%) and 178 (20.8%) of
children were born in spring and autumn,
respectively. There was no significance
relation between season of birth and CH
type (P=0.24) (Table.1).
The trends of incidence rate (per 1000 live
births) for CH cases are shown in Table.2.
The overall incidence rate for province
was 1.8, 2.3, 3.2, 4.3, 3.3, 4.0, 3.6, 4.6 and
2.7, respectively per 1000 neonates in this
period. This rate was increasing (1.8 in
2006 to 2.7 in 2014; 6.7% increase per
each year in this period). This trend only
for Gorveh and Sarvabad were decreasing;
but significance trend were shown only for
Divandareh with the 26.9% increase per
increase in these 9 years (P<0.05).
As shown in Figure.1, a geography
disparity was observed across Kurdistan
province because the spatial distribution of
incidence rate of CH varies at county level.
Generaly incidence rate of CH was higher
in North counties. Higher incidence rate of
CH were observed in Divandarreh County
in Nnorth and lowest in Qorveh County in
Southeast of Kurdistan province,
respectively. The mean birth weight of
permanent CH and transient CH neonates
was 3160 ± 613.7 and 31540 ± 599.5
grams, respectively. The mean TSH levels
Kaheni et al.
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4313
at first measurement in permanent were
significantly higher than transient CH
cases (14.1±17.6 vs. 11.3±16.2 mIU/L)
(P=0.04). Also, mean T4 levels at first
measurement in permanent CH cases were
8.8 ± 10.8 mIU/L and 11.4 ± 16 mIU/L in
transient CH cases. As shown in Table.3
and there was a significance differences
between T4 levels at fist measurement
permanent and transient CH patients
(P=0.04).
Table-1: Demographic and geographic distribution of CH neonates according CH type
Variables
Total (%)
Transient CH
No (%)
P-value
Unknown
No (%)
Gender
Boy
519(60.7)
322(64)
0.1
64(12.3)
Girl
336(39.3)
222(62.1)
45(13.4)
Residency
Urban
516(60.4)
324(62.8)
0.67
68(13.2)
Rural
339(39.6)
219(64.8)
41(12.1)
Parental
consanguinity
Absent
700(81.9)
460(65.7)
0.03
94(13.4)
Present
155(18.3)
94(60.7)
15(9.7)
Delivery Type
Normal vaginal
delivery
608(71.1)
395(65)
0. 3
74(12.2)
Cesarean section
247(28.9)
149(60.3)
35(14.2)
Season of birth
Spring
239(28.0)
155(64.8)
0.24
37(15.5)
Summer
203(23.8)
123(60.1)
22(10.8)
Autumn
178(20.8)
112(63.3)
21(11.9)
Winter
235(27.4)
153(65.3)
30(12.4)
Table-2: Trend of incidence rate (per 1000 live births) for Congenital Hypothyroidism in Kurdistan
province by county (2006-2014)
County
2006
2007
2008
2009
2010
2011
2012
2013
2014
AARR(I)
P-
value
Baneh
Fre
6
5
8
5
7
10
10
12
7
+2.2
0.49
IR
2.4
2.0
2.8
1.8
2.2
3.0
3.0
3.4
1.9
Bijar
Fre
3
3
4
4
6
9
4
3
3
+2.3
0.7
IR
2.0
1.5
2.7
2.6
4.2
6.2
2.7
1.9
1.9
Dehgolan
Fre
2
2
2
1
2
2
3
2
3
+2.42
0.55
IR
1.9
1.9
1.9
0.9
1.8
1.7
2.5
1.7
2.2
Diwandarreh
Fre
4
5
5
13
7
18
28
23
3
+26.9
0.003
IR
2.9
3.3
3.3
8.9
4.9
12.9
19.8
15.5
2.0
Qorveh
Fre
2
3
2
2
3
2
1
3
2
-3.6
0.44
IR
0.8
1.2
0.8
0.8
1.2
0.8
0.4
1.1
0.7
Kamyaran
Fre
5
14
12
5
9
14
12
9
22
+9.25
0.16
IR
2.7
7.8
6.2
2.6
4.7
7.5
6.3
4.9
11.0
Marivan
Fre
7
3
8
14
3
19
15
9
17
+11.1
0.23
IR
2.2
0.9
2.5
4.0
0.9
5.4
4.1
2.3
3.8
Saqqez
Fre
6
14
19
33
17
13
14
31
11
+4.9
0.5
IR
1.6
3.4
4.7
8.1
4.4
3.4
3.7
7.6
2.5
Sanandaj
Fre
10
10
24
38
33
20
13
40
14
+3.1
0.68
IR
1.5
1.4
3.4
5.0
4.4
2.6
1.6
4.9
1.6
Effect of Video Game Play on Pain
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4314
Sarvabad
Fre
3
2
2
3
2
1
1
2
2
-4.1
0.35
IR
3.4
2.4
2.5
3.6
2.6
1.6
1.4
2.8
2.7
Total
Fre
48
61
86
118
89
108
101
134
84
+6.7
0.1
IR
1.8
2.3
3.2
4.3
3.3
4.0
3.6
4.6
2.7
Fre: Frequency, IR: Incidence Rate per 1000 birth, AARR (I): average annual rate of reduction (increase).
Positive sign for AARR (I) represent increasing trend and negative sign represent decreasing trend.
Fig.1: Spatial distribution for CH mean incidence rate according counties in Kurdistan province
Table-3: Biochemical and anthropometric measures of CH neonates according CH type
Variables
Permanent CH
(mean± SD)
Transient CH
(mean ± SD)
P-value
Birth Weight (gr)
3160.1±613.7
3154.0±599.5
0.9
Length at Birth (cm)
49.5±5.97
48.3±7.6
0.3
TSH level at first measurement
(mIU/L)
14.13±17.6
11.3±16.2
0.04
T4 level at first measurement
(mIU/L)
8.8±10.8
11.4±16.0
0.04
Age at start of treatment (day)
21.15±13.2
21.44±14.1
0.8
4- DISCUSSION
The results of this study showed that
during the years 2006 to 2014, the number
of 855 infants were diagnosed with CH,
that 519 (60.7%) were boy and 516
patients (60.4%) were lived in urban areas.
202 (22.6%) of them were with permanent
hypothyroidism and 519 (63.6%) were
transient hypothyroidism. The number of
cases with transient hypothyroidism has
been more than permanent hypothyroidism
cases during the years 2006 to 2014.
Kaheni et al.
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4315
The mean age of start of treatment was
21.29 + 0.328 days in our study that was
21.15 + 0.027 days in permanent type and
21.44 + 0.142 days in transient type, and
no statistically significant difference was
found between age of start of treatment
and the type of hypothyroidism (transient
and permanent) that was consistent with
the study of Hashemipoor in Isfahan (23);
while, the mean age of start of treatment
was 38 days in the study of Kusdal in
Turkey that they have not seen it
appropriate and have mentioned delay in
conducting and receiving test results as the
reason (24).
In this study, the mean of weight and
height of infants with congenital
hypothyroidism were 3160 + 0.326 grams
and 49.5 + 0.028 cm, respectively, and
there was no statistically significant
relationship between weight and height of
infants with congenital hypothyroid
whereas was not consistent with the study
of Abedi et al. in Sanandaj in 2013 (25).
Investigation of annual incidence rate of
congenital hypothyroidism showed that
Divandareh city had the highest average of
annual incidence (+26.9) and this trend has
increased during the years 2006 to 2014
(P=0.003). Thus, the need for educational
programs in the field of prevention of
congenital hypothyroidism in this city
should be prioritized.
It seems that initially, doctors of
Divandarreh city were identified TSH
above 5 (instead of TSH above 10) as
patient and treated them which has been
lead to the increase in the prevalence of
this disease in this city that this criterion
has changed in recent years and TSH
above 10 has been defined as a patient.
The results of study showed that
congenital hypothyroidism was higher in
boys than girls and a significant
relationship between consanguineous
marriage and incidence of congenital
hypothyroidism disease was obtained.
In the study of Beheshti et al. in 2015 in
Mazandaran, the number of cases of
transient hypothyroidism was more than
permanent type (38.1% vs. 56.7%), which
was consistent with the results of our study
(11). In the study of Dareh et al. (2013) in
Markazi province- Iran, 122 patients were
with permanent hypothyroidism (29.5%)
and 113 patients were with transient
hypothyroidism (27.3%) of the total
patients (12). Disease incidence (transient
and permanent) in the province Kurdistan
is higher than the national average (1 in
300 vs. 1 in 414); of course, disease
incidence in the country is also higher than
many other countries which genetic and
environmental factors can be it causes due
to the high percentage of transient
hypothyroidism and that iodine deficiency
is the most common cause of incidence of
the transient type (13).
The prevalence of hypothyroidism is
variation in different regions in the world.
The difference between contractual criteria
which are considered in order to definitive
diagnosis of congenital hypothyroidism,
iodine deficiency in some areas of the
world and racial differences can be
mentioned as the causes of variety of the
prevalence of hypothyroidism in different
parts of the world (14); so that, it is 1 in 67
in Nigeria, and 1 in 781 live births in
Pakistan. Several studies in Iran show that
the prevalence amount of congenital
hypothyroidism was reported 1 in 950
births in Tehran, in Isfahan 1 in 342 live
births in 2002 and 1 in 333 live births in
2009, 1 in 1000 in Kerman, 1 in 446 in
Qazvin, and 1 in 397 live births in
Boroujerd (26). These statistics indicate
that the prevalence of congenital
hypothyroidism in Kurdistan province
compared to the global average (1 in 3,500
to 4,500 live births) is much higher and
almost in the average level of Statistics of
Iran (1 in 400 to 1 in 900 live births) (9).
The results of our study showed that 519
(60.7%) infants with hypothyroidism were
Effect of Video Game Play on Pain
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4316
boy and 336 (39.3%) are girl. In the
majority of research conducted, the
prevalence of the disease in females are
more than males (21), but in the present
study, sexual prevalence ratio of female
was obtained less than male (1 to 1,41),
although this difference was not
statistically significant. In the study
conducted in Isfahan, the prevalence in
females was less than males (1 to 1, 45),
which is consistent with the results of our
study (27).
In the study of Zitalzadeh et al., the
prevalence of congenital hypothyroidism
in boys were more than girls, but this
difference was not statistically significant
(P=0.38) (21). Recent years studies in Iran
show that hypothyroidism is slightly more
in boys (11, 28).The results of this study
showed that hypothyroidism is 516
(60.4%) in urban areas and 339 (39.6%) in
rural areas that this difference was not
statistically significant. In the study of
Mohammadi et al. (2012) in Kerman, the
prevalence of congenital hypothyroidism
in the village was significantly higher than
the city (20) that was not consistent with
our study. In the present study, the ratio of
consanguineous marriage to non-
consanguineous marriage in parents of
hypothyroidism infants was 20 to 80
percent. These ratios do not introduce the
effect of consanguineous marriage, but this
ratio was 70 to 30 percent in the study of
Tehran and Damavand. In the study of
Siami et al., the ratio of consanguineous
marriage to non- consanguineous marriage
in parents of hypothyroidism infants was
25 to 75 percent (29).
In the present study, the highest prevalence
of congenital hypothyroidism was seen in
spring and winter and the lowest in
summer and autumn which this difference
was not statistically significant (P=0.24).
In the study which was conducted in
Japan, most cases of congenital
hypothyroidism were in spring and winter
(30), which was consistent with the results
of our study. In another study in Yazd, the
highest prevalence of congenital
hypothyroidism has been in spring and
summer and the lowest in autumn and
winter, respectively (25). The seasonal
differences in the incidence of congenital
hypothyroidism indicate that several
factors such as genetic and environmental
factors can play a role in creating it (31).
The results of our study showed that TSH
range of infants was 11.3 mU/L in
transient type and 14.13 mU/L in
permanent type, and T4 level was 8.8
mu/L in permanent type and 11.4 mU/L in
transient type, and there was a significant
relationship between congenital
hypothyroidism and level of TSH and T4
(P=0.04). In the study of Beheshti et al.,
the mean of TSH was 24.19 mU/L (21).
In the study of Siami et al., the mean and
standard deviation of TSH and T4 in
hypothyroidism infants were 36.05±33.35
and 8.82±9.55, respectively (29). In the
present study, 71.7% of childbirth was
natural and 28.9% were cesarean, and no
significant relationship between the types
of childbirth and catching the transient and
permanent types of disease was obtained.
In the study of Beheshti et al. unlike our
study, the ratio of natural childbirth to
cesarean was (35.8% vs. 64.2%) (11).
4-1. Limitations of the study
Failure to accurately document existing
data in the health centers of cities of the
province can be mentioned as the
limitation of this study.
5- CONCLUSION
Given the high prevalence of congenital
hypothyroidism in Kurdistan and the
importance of this disease in creation of
mental retardation, informing people and
health care personnel in order to encourage
parents to participate in the screening
program of congenital hypothyroidism is
essential to be able to take preventive
interventions by a more detailed planning.
Kaheni et al.
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4317
Given that the prevalence of this disease
has been higher in Divandarreh city and
generally has an increasing trend in
Kurdistan province counties except
Sarvabad and Qorveh during recent years,
it emphasizes the need for further trainings
and the implementation of measures
planned for reducing the disease in the
city. Higher incidence rate of CH were
observed in Divandarreh county in North
and lowest in Qorveh County in Southeast
of Kurdistan province, respectively.
Complementary studies can provide a
clearer picture of the risk factors of this
disease in infants of the province for the
researchers.
6- CONFLICT OF INTEREST: None.
7- ACKNOWLEDGMENT
We offer our sincere appreciation for all
respected colleagues in the department of non-
communicable diseases and Healthcare
Department of Kurdistan University of
Medical Sciences and subsidiary cities that
assisted us in this research.
8- REFERENCES
1. LaFranchi SH. Approach to the
diagnosis and treatment of neonatal
hypothyroidism. The Journal of Clinical
Endocrinology & Metabolism
2011;96(10):2959-67.
2. Grüters A, Biebermann H, Krude H.
Neonatal thyroid disorders. Hormone Research
in Paediatrics 2004;59(Suppl. 1):24-9.
3. Ghaemi N, Vakili R, Bagheri S.
Precocious Puberty: An Unusual Presentation
of Hypothyroidism. International Journal of
Pediatrics 2013;1(2):51-4.
4. Vissenberg R, Van den Boogaard E,
Van Wely M, Van der Post J, Fliers E,
Bisschop P, et al. Treatment of thyroid
disorders before conception and in early
pregnancy: a systematic review. Human
reproduction update 2012;18(4):360-73.
5. Hashemipour M, Taghavi A, Karimi
DM, Amini M, Hovsepian S. Screening for
congenital hypothyroidism in Kashan, Iran. J
Mazandaran Univ Med Sci 2004, 14(45): 83-
92.
6. Lazarus JH, Bestwick JP, Channon S,
Paradice R, Maina A, Rees R, et al. Antenatal
thyroid screening and childhood cognitive
function. New England Journal of Medicine.
2012; 366(6):493-501.
7. Unnikrishnan AG, Menon UV.
Thyroid disorders in India: An
epidemiological perspective. Indian journal of
endocrinology and metabolism 2011;15(6):78-
83.
8. Köhler B, Schnabel D, Biebermann H,
Gruters A. Transient congenital
hypothyroidism and hyperthyrotropinemia:
normal thyroid function and physical
development at the ages of 6-14 years. J Clin
Endocrinol Metab 1996; 81:156367.
9. Rastogi MV, LaFranchi SH. Congenital
hypothyroidism. Rastogi and LaFranchi
Orphanet Journal of Rare Diseases
2010;5(17):1-22.
10. Ordookhani A, Minniran P, Najafi R,
Hedayati M, Azizi F. Congenital
hypothyroidism in Iran. The Indian Journal of
Pediatrics 2003;70(8):625-8.
11. Beheshti Z, Kosarian M, Rezaei S,
Saatsaz S, Nia HS, Sari M. Outcome of
Screening for Congenital Hypothyroidism in
Mazandaran Province: From Diagnosis to
Treatment. J Mazandaran Univ Med Sci 2015,
24(120): 30-42 .
12. Dorreh F, Yousefi CP, Javaheri J,
Eshrati B, Amiri Z. Evaluation of 6 years
performance of screening program of
congenital hypothyroidism in Markazi
province (2006-2012). Arak Medical
University Journal 2013; 16(8): 39-45.
13. Bhavani N. Transient congenital
hypothyroidism. Indian journal of
endocrinology and metabolism
2011;15(6):117.
14. Ojule A, Osotimehin B. Maternal and
neonatal thyroid status in Saki, Nigeria.
African journal of medicine and medical
sciences 1998;27(1-2):57-61.
15. Hall S, Hutchesson A, Kirk J.
Congenital hypothyroidism, seasonality and
consanguinity in the West Midlands, England.
Acta paediatrica 1999;88(2):212-5.
Effect of Video Game Play on Pain
Int J Pediatr, Vol.5, N.2, Serial No.38, Feb. 2017 4318
16. Akha O, Shabani M, Kosaryan M,
Ghafari V, Saravi SNS. Prevalence of
Congenital Hypothyroidism in Mazandaran
Province, Iran, 2008. Journal of Mazandaran
University of Medical Sciences (JMUMS)
2011;21(84):63-70.
17. Eftekhari N, Asadikaram GR,
Khaksari M, Salari Z, Ebrahimzadeh M. The
Prevalence Rate of Congenital
Hypothyroidism in Kerman. Iran in 2005-
2007. Journal of Kerman University of
Medical Sciences 2008;15(3):243-50.
18. Safari F, Karimzadeh T, Mostafavi F,
Mahram M. Screening of congenital
hypothyroidism in Qazvin province (2006-
2008). Journal of Qazvin University of
Medical Sciences 2009;12(4):49-57.
19. Dorreh F, Chaijan PY, Javaheri J,
Zeinalzadeh AH. Epidemiology of congenital
hypothyroidism in Markazi Province, Iran.
Journal of clinical research in pediatric
endocrinology 2014;6(2):105-111.
20. Mohammadi E, Baneshi MR, Nakhaee
N. The Incidence of Congenital
Hypothyroidism in Areas Covered by Kerman
and Jiroft Universities of Medical Sciences,
Iran. Journal of Health and Development
2012;1(1):47-55.
21. Zeinalzadeh AH, Kousha A, Talebi M,
Akhtari M. Screening for congenital
hypothyroidism in east Azerbaijan province,
Iran. Journal of Kerman University of Medical
Sciences 2014. 18(4): 301-309.
22 . Nili S, Ghaderi E, Ghotbi N, Baneh
FV. Comparison of iQ between patients with
treated Congenital hypothyroidism and healthy
Children in the Kurdish population-a
historiCal Cohort. Acta Endocrinologica
(Buc). 2015;11(3):299-305.
23. Hashemipour M, Dehkordi EH,
Hovsepian S, Amini M, Hosseiny L. Outcome
of congenitally hypothyroid screening program
in Isfahan: Iran from prevention to treatment.
International journal of preventive medicine
2010;1(2): 92-7.
24. Kusdal Y, Yesiltepe-Mutlu G, Özsu E,
Cizmecioglu FM, Hatun S. Congenital
hypothyroidism screening program in Turkey:
a local evaluation. The Turkish journal of
pediatrics 2012;54(6):590-5.
25. Abedi M, Shahsavari S, Salehi
Roghayeh, Hedayati Nia S, Nasrollahi S,
Sadeghi S, et al. The study of prevalence and
risk factors of hypothyroidism in newborn
screening program in Sanandaj city in 2009 -
2014 Journal of Medical Sciences Zankv
2014;1(1):46-51.
26. Namakin K, Sedighi E, Sharifzadeh G,
Zardast M. Prevalence of congenital
hypothyroidism In South Khorasan province
(2006-2010). Journal of Birjand University of
Medical Sciences. 2012;19(2):191-9
27. Hashemipour M, Amini M, Javaheri
N, Sattari G, Haghighi S, Hovsepian S, et al.
High prevalence of Congenital hypothyroidism
in Isfahan, Iran: results of a survey on 20,000
neonates.Horm Res 2004;62(2):79-83.
28. Noori Shadkam M, Jafarizadeh M,
Mirzaei M, Motlagh M, Eslami Z, Afkhami M,
et al. Prevalence of Congenital
Hypothyroidism and Transient Increased
Levels of TSH in Yazd Province. SSU
Journals 2008;16(3):315.
29. Siami R, Kosarian M, Vallaei N,
Hatami H ,Mirzajani M. Prevalence of
Congenital hypothyroidism and transient
increase TSH in babies born in the province.
Medical Journal 2013;37(4):244-52.
30. Nakamizo M, Toyabe Si, Asami T,
Akazawa K. Seasonality in the incidence of
congenital hypothyroidism in Japan. Journal of
paediatrics and child health 2005;41(7):390-3.
31. Olivieri A, Fazzini C, Medda E.
Multiple factors influencing the incidence of
congenital hypothyroidism detected by
neonatal screening. Hormone Research in
Paediatrics 2015;83(2):86-93.
... Genetic and congenital abnormalities are the most important cause of death and newborns' malformation in first month of life (1,2). Approximately 7.6 million newborns are born with severe genetic and congenital abnormalities in the world every year. ...
... Due to the contagion of the abnormalities in Iran, lack of diagnosing the disease and starting well-timed treatment in the first year of birth, cause to reduce children Intelligence Quotient (IQ). Also chronic cerebral lesions, mental retardation, muscle paralysis, liver problems and heart disease, are of other complications which impose heavy financial charge on families and government (1,2). Phenylketonuria (PKU), is among diseases which cause mental retardation in newborns. ...
... Lorestan is one of Western Province of Iran ( Figure. Lorestan is mountainous and is surrounded by Zagros Mountains except of several limited plains (2). Because the study of the incidence of the phenylketonuria in Lorestan had not ever conducted, this study is aimed to investigate the phenylketonuria during 2006-2016 in Lorestan province. ...
Article
Full-text available
Background: Phenylketonuria (PKU), is one of the most common metabolic diseases that resulted in mental retardation. The study aimed to investigate the incidence of phenylketonuria in Lorestan province, Iran. Materials and Methods: The study was an observational-descriptive study which included all identified cases of patients from April 2006 to February 2016. The required data were collected from patients' records. The Entered variables in data survey checklist included gender, date of birth, County Residence, parental education, parental occupation, parental kinship, conducting genetic consultation and screening. Recorded data were analyzed in Stata-12 software after completion. Results: Newborns were identified with Phenylketonuria during the years 2006 to 2016 and incidence rate calculated 1.91 per 10,000 live births. The highest incidence rate of disease was 3.86 per 10,000 live births in 2014. Delfan (Nurabad) County and Borujer County had maximum and minimum rate of incidence with 5.94 per 10,000 and 0.64 per 10,000, respectively. Among 74 patients, 42 (56%), were female and there was patients' parental kinship in 82% of parents that about 92 percent of suffering children parents had done genetic consultation. Conclusion: The incidence of phenylketonuria in the Lorestan province is more than other provinces. Given that most cases of patients resulted from cousin marriages, paying attention to the screening tests prior to marriage, particularly in familiar marriage is essential.
... Incidence of CH in the United States has doubled during 1987-2002 from 1 in 3985 to 1 in 2273 and again during 2002-2005 to 1 in 1415, similar to a rise reported in New Zealand, representative of their Asian population, during 1993-2010 [22]. The prevalence of CH is 1 in 650 in Turkey, 1 in 800 in Greece, 1 in 1000 in France [24], 1 in 1608 in Iran [25], 1 in 2372 in America, and 1 in 2640 in India [24]. However, over the past two decades, the worldwide prevalence of CH has increased dramatically from 1 in 1600 to 1 in 2800 live births; this variability in prevalence is related to environmental factors, changes in the ethnicity, race, and the method of screening in the population studied [23]. ...
... Incidence of CH in the United States has doubled during 1987-2002 from 1 in 3985 to 1 in 2273 and again during 2002-2005 to 1 in 1415, similar to a rise reported in New Zealand, representative of their Asian population, during 1993-2010 [22]. The prevalence of CH is 1 in 650 in Turkey, 1 in 800 in Greece, 1 in 1000 in France [24], 1 in 1608 in Iran [25], 1 in 2372 in America, and 1 in 2640 in India [24]. However, over the past two decades, the worldwide prevalence of CH has increased dramatically from 1 in 1600 to 1 in 2800 live births; this variability in prevalence is related to environmental factors, changes in the ethnicity, race, and the method of screening in the population studied [23]. ...
Article
Maternal hypothyroidism (MH) is the most common cause of transient congenital hypothyroidism. Different animal models are used for assessing developmental effects of MH in offspring. The severity and status of hypothyroidism in animal models must be a reflection of the actual conditions in humans. To obtain comparable results with different clinical conditions, which lead to MH in humans, several factors have been suggested for researchers to consider before designing the experimental models. Regarding development of fetal body systems during pregnancy, interference at different times provides different results and the appropriate time for induction of hypothyroidism should be selected based on accurate time of development of the system under assessment. Other factors that should be taken into consideration include, physiological and biochemical differences between humans and other species, thyroid hormone-independent effects of anti-thyroid drugs, circadian rhythms in TSH secretion, sex differences, physical and psychological stress. This review addresses essential guidelines for selecting and managing the optimal animal model for MH as well as discussing the pros and cons of currently used models.
... Thyroid problems during pregnancy is also one of other diseases that affect the health of the mother and consequently infant (51). Abortion, preterm delivery, and delay in fetal growth can be mentioned as undesirable consequences of hypothyroidism (52)(53)(54). ...
... Regarding hypothyroidism in pregnant mothers and its effect on birth weight, the results of this study has introduced it an important factor as weight disorder during pregnancy, but these results were not Thyroid and growth hormones are of the most important hormones that affect the development and growth process during fetal and childhood (52,58). In the first months of pregnancy, ten fetal thyroids are not still active and the fetus is highly dependent on the mother in terms of thyroid hormones; therefore, disorder in maternal thyroid hormones will have a significant impact on growth and development in infants (59). ...
Article
Full-text available
Background: Low birth weight (LBW) is considered as one of the important health indicators in evaluating prenatal care as well as determining scale of infants' health in the society. The study aimed to investigate maternal diseases during pregnancy and its impact on LBW in rural areas of Kurdistan province, Iran. Materials and Methods: This study was conducted in nested case-control study method in rural areas of Kurdistan province- Iran in 2015-2016. In this study, 182 infants less than 2,500gr as case and 364 infants weighing 2,500 g and more as control were entered the study. Information about case and control groups was extracted by investigating records of pregnant women care. Data was analyzed using software Stata-12 with point and interval estimation of odds ratio (OR) using conditional logistic regression. Results: The results of single-variable analysis of conditional logistic regression showed that there is a statistical relationship between blood pressure during pregnancy, iron deficiency anemia, mother's thyroid problems, oral and dental problems, and history of bleeding during pregnancy in case and control groups (P < 0.05). The results of multivariate analysis in the presence of other factors affecting underweight during pregnancy showed that there was statistically significant relationship between iron deficiency anemia (OR=23.86, 95%CI, 9.31-61.11), blood pressure during pregnancy (OR=13.8, 95%CI, 13.8-60.65), history of bleeding during pregnancy (OR=9.21, 95%CI, 3.39-25.01), and low birth weight (P < 0.05). Conclusion: The results of this study indicated significant relationship between the diseases of pregnancy (such as blood pressure during pregnancy, iron deficiency anemia, and history of bleeding during pregnancy) and Low birth weight in infants. The birth of a LBW infant can be to a large extent prevented by diagnosing and preventing these diseases and required trainings for pregnant women.
... Incidence of CH in the United States has doubled during 1987-2002 from 1 in 3985 to 1 in 2273 and again during 2002-2005 to 1 in 1415, similar to a rise reported in New Zealand, representative of their Asian population, during 1993-2010 [22]. The prevalence of CH is 1 in 650 in Turkey, 1 in 800 in Greece, 1 in 1000 in France [24], 1 in 1608 in Iran [25], 1 in 2372 in America, and 1 in 2640 in India [24]. However, over the past two decades, the worldwide prevalence of CH has increased dramatically from 1 in 1600 to 1 in 2800 live births; this variability in prevalence is related to environmental factors, changes in the ethnicity, race, and the method of screening in the population studied [23]. ...
... Incidence of CH in the United States has doubled during 1987-2002 from 1 in 3985 to 1 in 2273 and again during 2002-2005 to 1 in 1415, similar to a rise reported in New Zealand, representative of their Asian population, during 1993-2010 [22]. The prevalence of CH is 1 in 650 in Turkey, 1 in 800 in Greece, 1 in 1000 in France [24], 1 in 1608 in Iran [25], 1 in 2372 in America, and 1 in 2640 in India [24]. However, over the past two decades, the worldwide prevalence of CH has increased dramatically from 1 in 1600 to 1 in 2800 live births; this variability in prevalence is related to environmental factors, changes in the ethnicity, race, and the method of screening in the population studied [23]. ...
Article
Introduction: Human subjects can not always used as models for studying disease by researchers because of the potential risks for human health, and in addition, control of interfering factors is not easy in these subjects. Animal biology, physiology, anatomy, biochemistry, pharmacology, and genetics are very similar to humans. Animals are suitable models for research, as their functional body system is similar to humans and is easily manipulated. Most of our current knowledge in medical sciences is obtained from animal studies, among which, rats and mice are mostly used for the their shorter lifespans, which creates the possibility of producing many generations and studying total lifespan. The thyroid plays pivotal role in the body and is vital for normal function of almost all tissues throughout life. Decreased secretion of thyroid hormones from the thyroid gland (hypothyroidism) is a prevalent disorder and as a result animal models of hypothyroidism are often very important for research purposes. Thyroidectomy, genetic manipulation, and using anti-thyroid drugs are the most important ways to induce hypothyroidism in animals. The aim of this study was to review and evaluate different models for induction of hypothyroidism in rat, and in addition to compare the characteristics of rat and human thyroid glands. Conclusions: Anti-thyroid drugs could be used as cheap, available, and simple methods for inducing hypothyroidism, although they may also affect the function of other organs.
... Many maternal and fetal factors are significantly associated with LBW [10][11][12]. Based on the results obtained from various studies, these factors include the mother's age, occupation, weight, number of pregnancies, history of smoking, length of pregnancy, previous births, reproductive multiplication, inappropriate nutritional status, socioeconomic inequalities, lack of attention to proper diet and consumption of supplements during pregnancy, birth season, number of pregnancy cares and anemia, and birth defects, along with pre-pregnancy conditions and the socioeconomic status of the family related to LBW [5,11]. LBW birth outcomes are high, especially in developing countries and the third world. ...
Article
Full-text available
Infant mortality is among the most important indicators of health and development in global communities. One of the causes of neonatal mortality is low birth weight. This study aims at evaluating the risk factors for LBW in infants. This study was carried out using a nested case-control study in rural areas of Kurdistan province in Western Iran in 2015. The selection of case and control groups was based on the nesting using the risk set sampling approach. In total, 182 and 364 subjects were selected for the case group and the control group respectively. Data analysis was performed using the Stata-12 software with the point and spatial estimation of OR using the conditional logistic regression method. The multivariate logistic regression analysis performed shows that the maternal gestational age, the mother's health history during pregnancy, any medication abuses by the mother, any mental stress during pregnancy, are LBW risk factors (P < 0.05). Prevention of LBW is possible by identifying effective factors and performing appropriate interventions in infants with low birth weight.
... The reports also confirmed the incidence of cancer in Asians. [16][17][18][19] It is possible that this increase in the number of thyroid cancer cases is due to the improvement of diagnostic methods or further exposure to unknown risk factors. [20,21] Therefore, due to the nature and numerous factors affecting thyroid cancer, increasing the number of new cases, especially in female, and the increased mortality rate caused by this cancer around the world, this study was designed to evaluate thyroid cancer morbidity and mortality and its association with the Human Development Index (HDI) of societies in 2018. ...
... Hypothyroidism is associated with complications such as mental retardation, shortness and hearing loss; since the brain development continues until about three years, the complications of the disease are irreparable in the absence of early diagnosis and early onset of the treatment (5). According to Iranian hypothyroidism screening guideline Congenital hypothyroidism can be referred when Thyroid-Stimulating Hormone (TSH) is greater than 5 mu/l of heel sample in infants 3-5 d on filter paper (S&S 903 paper) and confirmation with venous blood samples TSH is greater than 10mu/l and thyroxin (T4) less than 6.5gr/dl (6). According to national studies, the prevalence of this disorder is higher than the global rate (7). ...
Article
Full-text available
Background: Congenital hypothyroidism is one of the most common endocrine disrupters and metabolism, and is one of the most important preventable causes of physical and mental disabilities. Methods: This was a case-control study, in which 54468 infants were screened from 2006 to 2014 in Shahre-Kord, western Iran. To describe the data, central and dispersion indices such as mean and standard deviation was used. For modeling, logistic regression was used. All the tests were performed at the significant level of 5%. Results: Overall, 111 cases were diagnosed with hypothyroidism, which made the prevalence value equal to 2 cases per 1000 births. The prevalence in females and males was 1.9 and 2.2 per 1,000 birth, respectively. The odds ratio for this disorder was 4.47(2.42-9.28) for the neonates with a family history of hypothyroidism and 1.72(1.05-2.82) for those born through cesarean. Conclusion: The incidence of this disorder is similar in males and females, and the incidence of this disease in people with a family history is far more than others.
... [27] In our previous study, the mean age of treatment was 22.9 ± 13.2 days of life. [24] It was also 21 days in another study in Kurdistan Province, Iran, [28] and 23 days in the screening program of Jordan. [3] These differences are the result of different screening methods. ...
Article
Full-text available
BACKGROUND: Considering the high prevalence rate of congenital hypothyroidism CH in Iran, an epidemiological study in each region would be helpful in understanding the etiology of the disorder and providing preventative strategies in this field. This study aims to determine the prevalence of CH in different cities of the Isfahan province. MATERIALS AND METHODS: This descriptive and retrospective study was conducted among 918 primarily diagnosed CH neonates, who have been identified through the neonatal screening program from 2009 to 2015. At the age of ≥3 years, treatment was discontinued for 4 weeks, and T4 and thyroid-stimulating hormone were measured. Permanent (PCH) or transient (TCH) was determined from the results of the thyroid function tests. RESULTS: From 389,101 screened neonates, 918 were diagnosed with primary CH. The overall prevalence rate of CH was 2.36 in 1000 live birth (ranged 1.58–7.22 in 1000 live birth in different cities). The highest prevalence rate of CH was reported in Ardestan, Khansar, Golpaygan, and Nain cities with prevalence rate of 4.86–7.22 in 1000 live birth and lowest prevalence occurring in Fereydan, Shahreza, Isfahan, and Mobarakeh cities with prevalence rate of 1.58–1.89 in 1000 live birth. In 392 cases which reached to 3 years of age, the rate of TCH was 47.45%. In Chadegan, Natanz, Fereydunshahr, Shahinshahr, Najafabad, Dehaghan, Borkhar, and Mobarakeh, the prevalence of PCH was
Article
Full-text available
Background and purpose: Congenital hypothyroidism (CH) is one of the most common preventable causes of mental disabilities. The present study was conducted to determine the prevalence of permanent and transient congenital hypothyroidism in Mazandaran province, Iran. Materials and methods: This retrospective descriptive survey was done based on medical records of children with primary diagnosis of congenital hypothyroidism between 2006 and 2014. Results: Until March 2012, 176250 infants were screened for congenital hypothyroidism of whom 389 were diagnosed with the disease (1 per 453 births). Among these cases, 169 had permanent CH (1 per 1043 births) and 220 had transient CH (1 per 801 births). Until 2014 a total of 269088 newborns was screened by which 548 case of primary congenital hypothyroidism were diagnosed (1 per 491 births) but their definitive diagnosis are not available until the next three years. The girl/boy ratio in permanent CH group was higher than that in transient CH (P=0.08). Conclusion: This study showed a high prevalence of transient and permanent hypothyroidism in Mazandaran, but transient CH was found to be more prevalent. Therefore, the factors affecting the development of transient CH and its higher incidence among male infants in Mazandaran province are required to be specifically investigated in future researches.
Article
Full-text available
Background: The congenital hypothyroidism (CH) is one of the most common congenital endocrine disorders as well as the most preventable mental retardation cause and body growth disorder. Several factors such as therapeutic interventions might affect the infants’ growth status. The current study was aimed to evaluate the therapeutic interventions’ effect on growth pattern of infants with congenital hypothyroidism in Yazd. Methods: This retrospective cohort study was performed on all neonates with CH, who were born during years 2006 and 2008. The effectiveness of therapeutic interventions indices including the age of treatment onset, the administered dosage of Levothyroxine and normalization time of T4 and TSH level on growth pattern of children with CH by measuring height, weight and head circumference during the first five years was evaluated. Results: The results of the current study showed a significant increase in height, weight, and head circumference in infants from early infancy to 60 months of age as well as an ascending trend of the aforementioned variables(P<0.05). Conclusion: The significant effect of therapeutic interventions such as the age of treatment onset less than 30 days, normalization time of TSH during 30 days after diagnosing and normalization age of T4 less than 14 days was reported on height and weight growths of patients with congenital hypothyroidism. Also, the trend of head circumference growth would be increased in patients equally.
Article
Full-text available
Background & Aims: Congenital hypothyroidism (CH) is one of the most common preventable causes of mental retardation throughout the world. The aim of this study was to investigate the prevalence of CH among newborns of East Azerbaijan province in 2009-2010. Methods: This descriptive analytic study was performed by using census cross- sectional method on 62459 neonates in East Azerbaijan province from 21st March 2009 to 20th March 2010. Blood samples were taken within the 3rd -5th days of life by lancet sticking of neonatal heel and transferred to filter papers for measuring TSH level. In the case of TSH ≥ 5mu/l, additional confirmation tests were done and confirmed cases based on serum confirmation test (TSH>10 mu/l or T4<6.5mg/dl) underwent treatment according to the national guidelines. Data were analyzed by SPSS software. Results: The recall rate was 2.5%. Total number of patients was 94, including 55 males (58.5%) and 39 females (41.5%). Prevalence in males, females and overall was respectively 1:588, 1:769 and 1:666, with no significant difference. Seasonal prevalence was respectively 1:833, 1:943, 1:492 and 1:588 that shows no significant difference among four seasons. The highest prevalence was in Tabriz (27.7%) and the lowest in Azarshahr (0%) and Kaleibar (0%). Mean maternal age of affected neonates was 26.22 ± 6.2 years. Mean neonate's weight was 3500 ± 652 grams. In 76% of neonates time of sampling was in the 3rd -5th days of life and in 89% of them test result was announced before 13th day. Mean treatment onset based on neonate's age was 2.7±1 day. In 97.5% of screened neonates TSH level was less than 5 mu/l. Conclusion: The prevalence of CH in East Azerbaijan province is significantly higher than national and worldwide levels that requires continuation and reinforcement of neonatal screening programs. On the other hand, comprehensive and complementary studies for recognizing relevant factors are among priorities of health system research in this province.
Article
Full-text available
Hypothyroidism is usually associated with delayed pubertal development but in rare occasions precocious puberty may ensue which is seen in cases of prolonged and untreated hypothyroidism. This is also called the Van Wyk Grumbach syndrome. Here we present 4 cases of precocious puberty due to hypothyroidism.
Article
Full-text available
Ob­jec­ti­ve: The aim of this study was to investigate the epidemiology of congenital hypothyroidism (CH) among newborns in Markazi Province, Iran. Methods: This cross-sectional study was conducted from 2006 to 2012. Blood samples were taken between 3 to 5 days after birth from the heel. Thyroid stimulating hormone (TSH) was tested using the enzyme-linked immunosorbent assay method and was employed as the screening test. Newborns with abnormal screening results (TSH >5 mIU/L) were re-examined. The data were analyzed using SPSS. Results: A total of 127 112 infants were screened. Of these, 51.2% were male and 48.8% were female. The coverage rate of the screening program was 100%. Of 6102 recalled subjects (re-call rate 4.8%), 414 cases with CH were detected, yielding a CH prevalence of 1:307 (female:male ratio 1:0.95). The prevalence of permanent and transient CH was 1:581 and 1:628, respectively. Conclusion: This study reveals that the prevalence of CH is higher compared to worldwide levels. Comprehensive and complementary studies for recognizing related risk factors should be a priority for health system research in this province.
Article
Full-text available
Background: Early detection and treatment are crucial to prevent mental retardation in congenital Hypothyroidism (CH). The aim of this study was to evaluate the screening program of CH in Markazi province. Material and Method: In this cross-sectional study we used recorded data in Markazi province health center. From 2006 to 2012, 127112 newborns were screened by measurement of serum TSH level by heel prick. Neonates who had blood TSH≥5MIU/L were recalled for more evaluation. Neonates with confirmed hypothyroidism underwent treatment. Results: From 127112 screened neonates, 414 were diagnosed as CH patients (both permanent and transient). The prevalence of CH was 1/307 in this province. Recall rate was 4.8 percent. In 94.4% of patients, treatment was begun before the 40 th day of life. The coverage percent in the province was 100% from the second year of the program. Conclusion: Recall rate and the incidence of CH were higher than those in other studies, both in Iran and other countries. The mean age of treatment initiation and coverage percent were in favorable range.
Article
Full-text available
Children born to women with low thyroid hormone levels have been reported to have decreased cognitive function. We conducted a randomized trial in which pregnant women at a gestation of 15 weeks 6 days or less provided blood samples for measurement of thyrotropin and free thyroxine (T(4)). Women were assigned to a screening group (in which measurements were obtained immediately) or a control group (in which serum was stored and measurements were obtained shortly after delivery). Thyrotropin levels above the 97.5th percentile, free T(4) levels below the 2.5th percentile, or both were considered a positive screening result. Women with positive findings in the screening group were assigned to 150 μg of levothyroxine per day. The primary outcome was IQ at 3 years of age in children of women with positive results, as measured by psychologists who were unaware of the group assignments. Of 21,846 women who provided blood samples (at a median gestational age of 12 weeks 3 days), 390 women in the screening group and 404 in the control group tested positive. The median gestational age at the start of levothyroxine treatment was 13 weeks 3 days; treatment was adjusted as needed to achieve a target thyrotropin level of 0.1 to 1.0 mIU per liter. Among the children of women with positive results, the mean IQ scores were 99.2 and 100.0 in the screening and control groups, respectively (difference, 0.8; 95% confidence interval [CI], -1.1 to 2.6; P=0.40 by intention-to-treat analysis); the proportions of children with an IQ of less than 85 were 12.1% in the screening group and 14.1% in the control group (difference, 2.1 percentage points; 95% CI, -2.6 to 6.7; P=0.39). An on-treatment analysis showed similar results. Antenatal screening (at a median gestational age of 12 weeks 3 days) and maternal treatment for hypothyroidism did not result in improved cognitive function in children at 3 years of age. (Funded by the Wellcome Trust UK and Compagnia di San Paulo, Turin; Current Controlled Trials number, ISRCTN46178175.).
Article
Full-text available
Thyroid disorders are associated with pregnancy complications. Universal screening is currently not recommended because of a lack of evidence on the effectiveness of treatment. Women with hyperthyroidism and hypothyroidism evidently require treatment but this is less clear for women with subclinical hypothyroidism and thyroid autoimmunity. Therefore, we conducted a systematic review to provide a comprehensive overview on the available treatment interventions. Relevant studies were identified by searching Medline, EMBASE and Cochrane Controlled Trials Register, published until December 2011. From a total of 7334 primary selected titles, 22 articles were included for the systematic review and 11 were appropriate for meta-analyses. Eight studies reported on hyperthyroidism. Propylthiouracil (PTU) and methimazole reduce the risk for preterm delivery [risk ratio (RR): 0.23, confidence interval (CI): 0.1-0.52], pre-eclampsia (RR: 0.23, CI: 0.06-0.89) and low birthweight (RR: 0.38, CI: 0.22-0.66). The nine studies that reported on clinical hypothyroidism showed that levothyroxine is effective in reducing the risk for miscarriage (RR: 0.19, CI: 0.08-0.39) and preterm delivery (RR: 0.41, CI: 0.24-0.68). For treatment of subclinical hypothyroidism, current evidence is insufficient. The five studies available on thyroid autoimmunity showed a not significant reduction in miscarriage (RR: 0.58, CI: 0.32-1.06), but significant reduction in preterm birth by treatment with levothyoxine (RR: 0.31, CI: 0.11-0.90). For hyperthyroidism, methimazole and PTU are effective in preventing pregnancy complications. For clinical hypothyroidism, treatment with levothyroxine is recommended. For subclinical hypothyroidism and thyroid autoimmunity, evidence is insufficient to recommend treatment with levothyroxine. The overall lack of evidence precludes a recommendation for universal screening and is only justified in a research setting.
Article
Background and purpose: Although congenital hypothyroidism is a preventable cause of mental disabilities, less than 10% of newborns are diagnosed based on clinical symptoms in the first month. If the diagnosis is not made based on screening programs, it would be delayed and irrepairable cerebral and auditory complications will occur. The purpose of this study was to determine the prevalence of congenital hypothyroidism in the Mazandaran province. Materials and methods: The study is a descriptive (screening) survey. From infants born from January 2007 to January 2008 in Mazandaran province heel blood samples on filter paper were obtained. TSH values were measured by ELISA method and TSH> 5 mlu/L was considered as the recall criterion. Diagnosis of neonatal hypothyroidism was made based on TSH>10 and T4<6.5. Treatment was performed based on the results of second tests. Except in cases where the initial TSH was greater or equal to 20 -where the treatment was started from the beginning- if the second test results were reported normal, treatment was discontinued and the case was considered as a transient hypothyroidism. Results: Out of 45218 infants studied, 49% were female and 51% were male. 4.6% of newborns (2109) were recalled, among whom 1885 had 5< TSH< 10 mlu/L and 185 had 10< TSH< 20 mlu/L and 39 had TSH ≥ 20.73 infants were diagnosed with hypothyroidism. Thus, the prevalence of neonatal hypothyroidism was 1.6/1000 in live births in Mazandaran province. Also prevalence of transient neonatal hypothyroidism was 1 in every 2500 live births. Conclusion: Given the high prevalence of hypothyroidism in the province, more screening programs are essential.
Article
It was aimed to evaluate the national congenital hypothyroidism program in terms of thyroid-stimulating hormone (TSH) cut-off level, frequency of cases that required treatment and the stages before treatment in the Kocaeli district area. This research was performed with the contribution of Kocaeli University Medical Faculty, Pediatric Endocrinology Department, and the Kocaeli Local Health District. 25,188 babies born in 2009 were evaluated. The previous laboratory data including heel prick samples and venous thyroid function tests (TSH, free/total T4 levels) of babies requiring investigation were evaluated retrospectively. 49,785 heel prick blood samples were collected from 25,188 babies born in our region. TSH levels of 3,355 babies in the first sampling were greater than the cut-off level (15 mIU/L) (recall rate was 13.3%). Venous sampling was required for 107 babies, and 39 of them needed to be treated (treatment rate was 1/645). Eleven of the babies who were treated were diagnosed with thyroid dysgenesis. Families of the babies who needed further venous sampling were given final results in an average of 28.5 days after the first heel sampling. We concluded that the recall rate is high, but raising the cut-off level for TSH may lead to overlooking the diagnosis of thyroid dysgenesis. The duration for providing final results to the families is quite long. It is necessary to take venous blood samples in the pediatric endocrinology units to reduce this duration.
Article
Congenital hypothyroidism, occurring in 1:3000 newborns, is one of the most common preventable causes of mental retardation. Neurodevelopmental outcome is inversely related to the age of diagnosis and treatment. Infants detected through newborn screening programs and started on l-T(4) in the first few weeks of life have a normal or near-normal neurodevelopmental outcome. The recommended starting dose of l-T(4) (10-15 μg/kg · d) is higher on a weight basis than the dose for children and adults. Tailoring the starting l-T(4) dose to the severity of the hypothyroidism will normalize serum T(4) and TSH as rapidly as possible. It is important to obtain confirmatory serum thyroid function tests before treatment is started. Further diagnostic studies, such as radionuclide uptake and scan and ultrasonography, may be performed to determine the underlying cause of hypothyroidism. Because results from these tests generally do not alter the initial treatment decision, however, these diagnostic studies are rarely indicated. The developing brain has a critical dependence on thyroid hormone for the first 2-3 yr of life; thus, monitoring occurs at more frequent intervals than in older children and adults. Serum free T(4) and TSH should be checked at intervals frequent enough to ensure timely adjustment of l-T(4) dosing and to keep serum free T(4) and TSH levels in target ranges. Given the success of early detection and treatment of neonates with congenital hypothyroidism, a public health mandate should be to develop similar programs for the 75% of babies worldwide who are born in areas without newborn screening programs.